Hyperbaric oxygen therapy for control of intractable cyclophosphamide-induced hemorrhagic cystitis. | Canada Hyperbarics Skip to main content
Clinical Study European urology 1992

Hyperbaric oxygen therapy for control of intractable cyclophosphamide-induced hemorrhagic cystitis.

Shameem IA, Shimabukuro T, Shirataki S, Yamamoto N, Maekawa T, Naito K — European urology, 1992

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers reported on a single case where hyperbaric oxygen therapy was used to treat intractable cyclophosphamide-induced hemorrhagic cystitis.

What They Found

After 8 consecutive weeks of hyperbaric oxygen therapy at an absolute pressure of 2 atm, the patient's bleeding completely ceased. The patient remained free of hematuria thereafter, and no side effects were observed during the course of therapy.

Canadian Relevance

This study has no direct Canadian connection as it was not conducted in Canada or by Canadian researchers.

Study Limitations

A significant limitation of this study is that it is a single case report, which limits the generalizability of its findings to a broader patient population.

This plain-language summary is generated with AI assistance and checked against the source abstract before publication. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Clinical Study
Category Uncategorised
Source Pubmed
PubMed ID 1468485
Year Published 1992
Journal European urology
MeSH Terms Cyclophosphamide; Cystitis; Female; Granulomatosis with Polyangiitis; Hemorrhage; Humans; Hyperbaric Oxygenation; Middle Aged

Cite This Study

Share

Find a Canadian Clinic Treating Uncategorised

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last reviewed: April 2, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology